327 related articles for article (PubMed ID: 9879409)
21. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy and immunological changes in children with allergic rhinitis receiving specific immunotherapy with Dermatophagoides pteronyssinus].
Wang CS; Zhang W; Wang XD; Xi L; Ouyang YH; Zhao Y; Wang Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 46(1):36-9. PubMed ID: 21429334
[TBL] [Abstract][Full Text] [Related]
23. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
Modrzyński M; Mazurek H; Zawisza E
Przegl Lek; 2005; 62(12):1337-42. PubMed ID: 16786743
[TBL] [Abstract][Full Text] [Related]
24. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
25. A new method of administration of topical nasal extracts. Immunoaerosol therapy.
Sánchez Palacios A; Sánchez Palacios MA; García Marrero JA
Allergol Immunopathol (Madr); 1992; 20(4):135-8. PubMed ID: 1485592
[TBL] [Abstract][Full Text] [Related]
26. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
Kim ST; Han DH; Moon IJ; Lee CH; Min YG; Rhee CS
Am J Rhinol Allergy; 2010; 24(4):271-5. PubMed ID: 20819465
[TBL] [Abstract][Full Text] [Related]
27. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
28. [Long-term efficacy of Dermatophagoides pteronyssinus immunotherapy in patients with allergic rhinitis: a 3-year prospective study].
Wang CS; Wang XD; Zhang W; She WY; Xi L; Ouyang YH; Zhao Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):804-8. PubMed ID: 23302159
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy of steroid nasal spray versus antihistamine nasal spray in allergic rhinitis.
Ghimire A; Das BP; Mishra SC
Nepal Med Coll J; 2007 Mar; 9(1):17-21. PubMed ID: 17593672
[TBL] [Abstract][Full Text] [Related]
31. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
Muñoz-López F; Martín Mateos A; Moreira A; Martínez Marín F
Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
[No Abstract] [Full Text] [Related]
32. Long-term immunotherapy for perennial allergic rhinitis: relationship of specific IgG levels to skin-prick test results and clinical symptoms and signs.
Tahamiler R; Canakcioglu S; Yilmaz S; Isildak H
Ear Nose Throat J; 2008 Dec; 87(12):E29. PubMed ID: 19105132
[TBL] [Abstract][Full Text] [Related]
33. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
34. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
35. [Clinical efficacy of immunotherapy with house dust in the patients with perennial nasal allergy].
Takeuchi K; Kishioka C; Yuta A; Sakakura Y; Masuda S; Ukai K; Majima Y
Arerugi; 2000 Aug; 49(8):627-33. PubMed ID: 11021014
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites.
Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW
Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583
[TBL] [Abstract][Full Text] [Related]
37. Topical nasal immunotherapy. Immunologic response of IgE in nasal secretion after immunotherapy with Dermatophagoides pteronyssinus.
Martín Mateos MA; Monferrer R; Muñoz López F
Allergol Immunopathol (Madr); 1990; 18(4):223-8. PubMed ID: 2264553
[TBL] [Abstract][Full Text] [Related]
38. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
Gastpar H; Dorow P; Aurich R; Petzold U
Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial asthma accompanied with allergic rhinitis: a randomized, double blind, placebo-controlled study.
Li J; Luo DF; Li SY; Sun BQ; Zhong NS
Chin Med J (Engl); 2005 Oct; 118(19):1595-603. PubMed ID: 16232343
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy.
Lin HC; Lin PW; Su CY; Chang HW
Laryngoscope; 2003 Apr; 113(4):673-8. PubMed ID: 12671427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
